The second of two pivotal studies of a six-monthly HIV prevention injection containing the antiretroviral drug lenacapavir ...

Those include Sunlenca, which is approved for resistant HIV as a twice-yearly injection after an initial oral regimen, and ...

Progress has been made in HIV care. However, that doesn’t mean you don’t need a detailed plan for taking care of an ...

As groundbreaking studies continue to reshape the human immunodeficiency virus (HIV) landscape, emerging therapies and ...

Gilead Sciences, the maker of a twice-a-year anti-HIV injection, has approached South Africa’s medicine regulator to discuss ...

The Institute of Human Virology, Nigeria (IHVN) has said it is pioneering a research project to develop a vaccine targeting ...

These young people are much more likely to experience treatment failure than ... July 2, 2024 — A major challenge in developing a vaccine for HIV is that the virus mutates fast -- very fast.

Namibia has made significant strides in stemming the spread of HIV and AIDS through education and prevention. However, for people like Anna Engomba, the arrival of new, life-saving medication cannot ...

Poverty disproportionately affects women and girls, who may face additional barriers such as gender-based violence and lack ...

They appreciate concepts of transmission, protection and vaccine availability at ... “Most of them had advanced HIV ... and [were] not on treatment,” Ogoina says. People with HIV accounted ...

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...

Health NGO, Right to Care, highlights the urgent need for circumcision among boys aged 15 and older in KwaZulu-Natal to ...